Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
Kitsada Wudhikarn, Jeffery J. Auletta(Nationwide Children's Hospital), Min Chen(Allen Institute for Brain Science), Marcie Riches(Medical College of Wisconsin), Siddhartha Ganguly(University of Kansas Medical Center), Mohamed A. Kharfan‐Dabaja(Jacksonville College), Giancarlo Fatobene(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Melody Smith(Memorial Sloan Kettering Cancer Center), Hemant S. Murthy(University of Florida), Zeinab El Boghdadly(The Ohio State University Wexner Medical Center), Kirsten M. Williams(National Institutes of Health), Amer Beitinjaneh(University of Miami), Jennifer Holter‐Chakrabarty(University of Oklahoma Health Sciences Center), Tania Jain(Johns Hopkins University), Muhammad Bilal Abid(Aga Khan University), John H. Baird(City Of Hope National Medical Center), Jo‐Anne H. Young(University of Minnesota System), Paschalis Vergidis(Mayo Clinic), Amar H. Kelkar(Harvard University), Taiga Nishihori(Moffitt Cancer Center), Hemalatha G. Rangarajan(Nationwide Children's Hospital), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Roy F. Chemaly(The University of Texas MD Anderson Cancer Center), Dwight E. Yin(National Institutes of Health), Akshay Sharma(St. Jude Children's Research Hospital), Usama Gergis(Thomas Jefferson University Hospital), Natalie S. Grover(University of North Carolina at Chapel Hill), Megan M. Herr(Roswell Park Comprehensive Cancer Center), Christopher G. Kanakry(National Cancer Institute), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Marjorie Vieira Batista(AC Camargo Hospital), Anna R. Huppler(Medical College of Wisconsin), Dipenkumar Modi(Wayne State University), Michael J. Martens(Medical College of Wisconsin), Lohith Gowda(Yale Cancer Center), Baheyeldin Salem(Baylor College of Medicine)
Cited by 16
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k